This unit was housed two stories above the Laboratory of Molecular Endocrinology, also part of the Department of Medicine, and headed by physician-endocrinologist Joel Habener
What It Is Class: Triple agonist targeting GLP-1R, GIPR, and GCGR Concept: Combines incretin-based GLP-1/GIP signaling with glucagon-receptor activity to jointly influence appetite, glucose handling, and energy expenditure in research settings
Some questions to consider include: What are the potential benefits and risks of semaglutide for my specific situation
Benefits: Fiber promotes feelings of fullness, aids digestion, regulates blood sugar spikes, and contributes to overall digestive health
If you are monitoring your blood glucose at home, continue your usual testing schedule and record your results according to your diabetes care plan